GHK-Cu – Injection

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper peptide complex formed by the tripeptide GHK and copper(II) ions. It belongs to the class of copper peptides, which are small bioactive peptides with a strong affinity for copper ions, playing important roles in cellular signaling and tissue repair. GHK-Cu is not an FDA-approved medication but is widely used in cosmetics, regenerative medicine, and compounding pharmacy for its reparative and anti-aging properties. It is primarily utilized for skin rejuvenation, wound healing, and anti-inflammatory purposes. Its therapeutic applications include improving skin elasticity, reducing fine lines and wrinkles, promoting collagen and glycosaminoglycan synthesis, enhancing angiogenesis (new blood vessel formation), and modulating gene expression to restore tissue health. Unlike traditional medications, GHK-Cu is a biomimetic peptide complex that differs from other anti-aging or wound healing agents by its ability to modulate multiple cellular pathways simultaneously, including growth factor expression, matrix metalloproteinase activity, and antioxidant defenses. This pleiotropic activity makes it unique compared to single-target drugs or topical agents. Key benefits for patients include: - Enhanced wound healing through stimulation of angiogenesis and collagen production. - Anti-inflammatory and antioxidant effects that protect and repair skin. - Improvement in skin firmness, elasticity, and clarity. - Reduction of hyperpigmentation and protection against UV damage. - Potential stimulation of hair growth and nerve regeneration. The general safety profile of GHK-Cu is favorable, with low toxicity reported. It is naturally present in human plasma, saliva, and urine, and its levels decline with age, correlating with decreased regenerative capacity. Adverse effects are rare, but as with any peptide therapy, potential for local irritation or allergic reactions exists, especially with injectable formulations. From a compounding pharmacy perspective, GHK-Cu is typically formulated as a sterile injectable solution for intradermal or subcutaneous administration, or as a topical preparation in creams or serums. Key compounding considerations include: - Maintaining sterility and stability of the peptide-copper complex. - Using appropriate buffers and preservatives to preserve activity. - Ensuring correct concentration and pH to optimize bioavailability and minimize irritation. - Packaging in light-protective containers to prevent degradation. - Proper storage, usually refrigerated, to maintain potency. Formulations may vary depending on intended use (cosmetic vs. therapeutic), route of administration, and patient-specific factors. Compounding pharmacists must adhere to aseptic techniques and validate formulations for purity and potency. In summary, GHK-Cu is a naturally derived copper peptide complex with multifaceted regenerative and anti-aging effects, used primarily in compounding for skin and tissue repair applications. Its unique mechanism, safety profile, and broad biological activity distinguish it from conventional medications, making it a valuable agent in personalized peptide therapy.

GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Copper Complex):

• Copper-binding peptide investigated for regenerative properties
• Has been reported to affect collagen and elastin production
• Has been reported to affect angiogenesis (blood vessel formation)
• Modulates metalloproteinases (tissue remodeling)
• Anti-inflammatory effects
• Antioxidant activity
• Has been reported to affect stem cell activation

Profile

Well-Tolerated: No major adverse effects at standard doses

Common Side Effects (Minimal):

• Injection site reactions (mild)
• Transient redness with topical use
• Rare: Metallic taste

Contraindications:

• Copper sensitivity/allergy
• Wilson's disease (copper metabolism disorder)
• Hemochromatosis (consider copper load)

Contraindications and Precautions for GHK-Cu (Copper Peptide):